期刊
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
卷 53, 期 4, 页码 1657-1659出版社
AMER SOC MICROBIOLOGY
DOI: 10.1128/AAC.00998-08
关键词
-
资金
- Pfizer Pharmaceuticals Group, New York, NY
The in vitro activities of fluconazole and voriconazole against 1,024 clinical isolates of Candida spp. were determined by the agar disk diffusion test using the Clinical and Laboratory Standards Institute (CLSI) M44-A guidelines. The results of this investigation demonstrated the broad-spectrum in vitro activity of voriconazole, relative to that of fluconazole, against yeasts tested, in particular fluconazole-resistant isolates, such as Candida krusei that showed high susceptibility to voriconazole. The situation in Turin, Italy, is quite similar to that of the rest of Italy, reflecting the worldwide trend.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据